Literature DB >> 23474710

Why should autophagic flux be assessed?

Xiao-jie Zhang1, Sheng Chen, Kai-xing Huang, Wei-dong Le.   

Abstract

As autophagy is involved in cell growth, survival, development and death, impaired autophagic flux has been linked to a variety of human pathophysiological processes, including neurodegeneration, cancer, myopathy, cardiovascular and immune-mediated disorders. There is a growing need to identify and quantify the status of autophagic flux in different pathological conditions. Given that autophagy is a highly dynamic and complex process that is regulated at multiple steps, it is often assessed accurately. This perspective review article will focus on the autophagic flux defects in different human disorders and update the current methods of monitoring autophagic flux. This knowledge is essential for developing autophagy-related therapeutics for treating the diseases.

Entities:  

Mesh:

Year:  2013        PMID: 23474710      PMCID: PMC4002868          DOI: 10.1038/aps.2012.184

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  47 in total

Review 1.  Autophagy gone awry in neurodegenerative diseases.

Authors:  Esther Wong; Ana Maria Cuervo
Journal:  Nat Neurosci       Date:  2010-07       Impact factor: 24.884

Review 2.  Autophagy fights disease through cellular self-digestion.

Authors:  Noboru Mizushima; Beth Levine; Ana Maria Cuervo; Daniel J Klionsky
Journal:  Nature       Date:  2008-02-28       Impact factor: 49.962

3.  Assaying of autophagic protein degradation.

Authors:  Chantal Bauvy; Alfred J Meijer; Patrice Codogno
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

4.  Methods in mammalian autophagy research.

Authors:  Noboru Mizushima; Tamotsu Yoshimori; Beth Levine
Journal:  Cell       Date:  2010-02-05       Impact factor: 41.582

5.  Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations.

Authors:  Ju-Hyun Lee; W Haung Yu; Asok Kumar; Sooyeon Lee; Panaiyur S Mohan; Corrinne M Peterhoff; Devin M Wolfe; Marta Martinez-Vicente; Ashish C Massey; Guy Sovak; Yasuo Uchiyama; David Westaway; Ana Maria Cuervo; Ralph A Nixon
Journal:  Cell       Date:  2010-06-10       Impact factor: 41.582

Review 6.  Autophagy: cellular and molecular mechanisms.

Authors:  Danielle Glick; Sandra Barth; Kay F Macleod
Journal:  J Pathol       Date:  2010-05       Impact factor: 7.996

7.  Distinct regulation of autophagic activity by Atg14L and Rubicon associated with Beclin 1-phosphatidylinositol-3-kinase complex.

Authors:  Yun Zhong; Qing Jun Wang; Xianting Li; Ying Yan; Jonathan M Backer; Brian T Chait; Nathaniel Heintz; Zhenyu Yue
Journal:  Nat Cell Biol       Date:  2009-03-08       Impact factor: 28.824

8.  The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice.

Authors:  Fiona Pickford; Eliezer Masliah; Markus Britschgi; Kurt Lucin; Ramya Narasimhan; Philipp A Jaeger; Scott Small; Brian Spencer; Edward Rockenstein; Beth Levine; Tony Wyss-Coray
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

Review 9.  p62 at the crossroads of autophagy, apoptosis, and cancer.

Authors:  Jorge Moscat; Maria T Diaz-Meco
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

10.  Does bafilomycin A1 block the fusion of autophagosomes with lysosomes?

Authors:  Daniel J Klionsky; Zvulun Elazar; Per O Seglen; David C Rubinsztein
Journal:  Autophagy       Date:  2008-10-22       Impact factor: 16.016

View more
  108 in total

1.  Autophagy inhibits cell death induced by the anti-cancer drug morusin.

Authors:  Sang Woo Cho; Wooju Na; Minji Choi; Shin Jung Kang; Seok-Geun Lee; Cheol Yong Choi
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

2.  Nicotinamide riboside promotes autolysosome clearance in preventing doxorubicin-induced cardiotoxicity.

Authors:  Dong Zheng; Yi Zhang; Ming Zheng; Ting Cao; Grace Wang; Lulu Zhang; Rui Ni; Joseph Brockman; Huiting Zhong; Guo-Chang Fan; Tianqing Peng
Journal:  Clin Sci (Lond)       Date:  2019-07-15       Impact factor: 6.124

3.  Blocking Autophagy in Oligodendrocytes Limits Functional Recovery after Spinal Cord Injury.

Authors:  Sujata Saraswat Ohri; Andrew N Bankston; S Ashley Mullins; Yu Liu; Kariena R Andres; Jason E Beare; Russell M Howard; Darlene A Burke; Amberly S Riegler; Allison E Smith; Michal Hetman; Scott R Whittemore
Journal:  J Neurosci       Date:  2018-05-23       Impact factor: 6.167

4.  Sulfuretin protects hepatic cells through regulation of ROS levels and autophagic flux.

Authors:  Yu-Ting Lu; Yu-Feng Xiao; Yu-Feng Li; Jia Li; Fa-Jun Nan; Jing-Ya Li
Journal:  Acta Pharmacol Sin       Date:  2018-12-18       Impact factor: 6.150

5.  Acquisition of docetaxel resistance in breast cancer cells reveals upregulation of ABCB1 expression as a key mediator of resistance accompanied by discrete upregulation of other specific genes and pathways.

Authors:  Stine Ninel Hansen; David Westergaard; Mathilde Borg Houlberg Thomsen; Mette Vistesen; Khoa Nguyen Do; Louise Fogh; Kirstine C Belling; Jun Wang; Huanming Yang; Ramneek Gupta; Henrik J Ditzel; José Moreira; Nils Brünner; Jan Stenvang; Anne-Sofie Schrohl
Journal:  Tumour Biol       Date:  2015-01-18

6.  Increased autophagic degradation contributes to the neuroprotection of hydrogen sulfide against cerebral ischemia/reperfusion injury.

Authors:  Yuanjun Zhu; Mengyang Shui; Xiaoyan Liu; Wenhui Hu; Yinye Wang
Journal:  Metab Brain Dis       Date:  2017-04-18       Impact factor: 3.584

Review 7.  Autophagy modulation for Alzheimer's disease therapy.

Authors:  Xi-Chen Zhu; Jin-Tai Yu; Teng Jiang; Lan Tan
Journal:  Mol Neurobiol       Date:  2013-04-27       Impact factor: 5.590

8.  Sulindac-derived retinoid X receptor-α modulator attenuates atherosclerotic plaque progression and destabilization in ApoE-/- mice.

Authors:  Linghong Shen; Zhe Sun; Peng Nie; Ruosen Yuan; Zhaohua Cai; Caizhe Wu; Liuhua Hu; Shuxuan Jin; Hu Zhou; Xiaokun Zhang; Ben He
Journal:  Br J Pharmacol       Date:  2019-05-23       Impact factor: 8.739

9.  Pivotal role of mitophagy in response of acute myelogenous leukemia to a ceramide-tamoxifen-containing drug regimen.

Authors:  Samy A F Morad; Matthew R MacDougall; Noha Abdelmageed; Li-Pin Kao; David J Feith; Su-Fern Tan; Mark Kester; Thomas P Loughran; Hong-Gang Wang; Myles C Cabot
Journal:  Exp Cell Res       Date:  2019-05-18       Impact factor: 3.905

10.  Heat shock factor 1 confers resistance to Hsp90 inhibitors through p62/SQSTM1 expression and promotion of autophagic flux.

Authors:  Buddhini Samarasinghe; Christina T K Wales; Frederick R Taylor; Aaron T Jacobs
Journal:  Biochem Pharmacol       Date:  2013-11-28       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.